Correlation Between Cytek Biosciences and EUDA Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cytek Biosciences and EUDA Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytek Biosciences and EUDA Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytek Biosciences and EUDA Health Holdings, you can compare the effects of market volatilities on Cytek Biosciences and EUDA Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytek Biosciences with a short position of EUDA Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytek Biosciences and EUDA Health.

Diversification Opportunities for Cytek Biosciences and EUDA Health

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Cytek and EUDA is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and EUDA Health Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EUDA Health Holdings and Cytek Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytek Biosciences are associated (or correlated) with EUDA Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EUDA Health Holdings has no effect on the direction of Cytek Biosciences i.e., Cytek Biosciences and EUDA Health go up and down completely randomly.

Pair Corralation between Cytek Biosciences and EUDA Health

Given the investment horizon of 90 days Cytek Biosciences is expected to generate 21.13 times less return on investment than EUDA Health. But when comparing it to its historical volatility, Cytek Biosciences is 1.66 times less risky than EUDA Health. It trades about 0.01 of its potential returns per unit of risk. EUDA Health Holdings is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  148.00  in EUDA Health Holdings on August 31, 2024 and sell it today you would earn a total of  295.00  from holding EUDA Health Holdings or generate 199.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cytek Biosciences  vs.  EUDA Health Holdings

 Performance 
       Timeline  
Cytek Biosciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cytek Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward-looking signals, Cytek Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.
EUDA Health Holdings 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in EUDA Health Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent fundamental indicators, EUDA Health may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Cytek Biosciences and EUDA Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cytek Biosciences and EUDA Health

The main advantage of trading using opposite Cytek Biosciences and EUDA Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytek Biosciences position performs unexpectedly, EUDA Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EUDA Health will offset losses from the drop in EUDA Health's long position.
The idea behind Cytek Biosciences and EUDA Health Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated